[Upper airway obstruction by angioedema following thrombolytic therapy with recombinant tissue plasminogen activator].
García-Jiménez
A
A
Iriarte Sotés
P
P
Fernández González
C J
CJ
Garrote Freire
A
A
González Tutor
J
J
D000368:Aged; D000402:Airway Obstruction / Q000139:chemically induced* / Q000188:drug therapy; D000799:Angioedema / Q000139:chemically induced* / Q000188:drug therapy; D018926:Anti-Allergic Agents / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy; D012131:Respiratory Insufficiency / Q000139:chemically induced* / Q000188:drug therapy; D015912:Thrombolytic Therapy / Q000009:adverse effects* / Q000379:methods; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000009:adverse effects*; D016896:Treatment Outcome
D018926:Anti-Allergic Agents; D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator